Results 51 to 60 of about 1,127,554 (354)

F-18-FDG and C-11-choline positron emission tomography in human esophago-gastric cancer : prediction of response to therapy [PDF]

, 2010
Peer reviewedPublisher ...
Hammonds, Solveig, McAteer, Dympna, Nicolson, Marianne, Park, Kenneth, Schweiger, Lutz, Sheehan, Margaret, Smith, Timothy, Suttie, Stuart, Welch, Andrew   +8 more
core   +1 more source

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Radiation Oncology, 2019
Purpose Neoadjuvant chemoradiation or chemotherapy has improved the treatment efficacy of patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma (PDAC).
Qiancheng Hu, Dan Wang, Ye Chen, Xiaofen Li, Peng Cao, Dan Cao   +5 more
doaj   +1 more source

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +2 more sources

Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy

JAMA Network Open, 2022
Key Points Question Is adjuvant chemotherapy associated with a survival benefit for patients with locally advanced gastric cancer who underwent curative-intent gastrectomy after neoadjuvant chemotherapy? Findings In this cohort study of 462 patients with
Jian-Xian Lin, Yi-hui Tang, Guangtan Lin, Yu-bin Ma, J. Desiderio, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, L. Cao, Mi Lin, R. Tu, C. Zheng, A. Parisi, M. Truty, Chang-ming Huang   +16 more
semanticscholar   +1 more source

The Impact of Neoadjuvant versus Adjuvant Chemotherapy on Survival Outcomes in Locally Advanced Breast Cancer

Current Oncology
The utility of neoadjuvant chemotherapy is expanding in the treatment of breast cancer. Although individual trials have shown comparable survival between patients receiving neoadjuvant and adjuvant chemotherapy, large-scale data analyses for outcomes in ...
Farhad Ghasemi, Muriel Brackstone
doaj   +1 more source

Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis

World Journal of Surgical Oncology, 2021
Background Hepatectomy for resectable colorectal liver metastasis (CRLM) is recommended. However, the efficacy of upfront hepatectomy without neoadjuvant chemotherapy (NAC) is unclear due to the uncertainty of perioperative systemic chemotherapy ...
Kosuke Ono, Tomoyuki Abe, Akihiko Oshita, Yusuke Sumi, Takuya Yano, Hiroshi Okuda, Manabu Kurayoshi, Tsuyoshi Kobayashi, Hideki Ohdan, Toshio Noriyuki, Masahiro Nakahara   +10 more
doaj   +1 more source

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer

International Journal of Molecular Sciences, 2021
Breast cancer has an extremely high incidence in women, and its morbidity and mortality rank first among female tumors. With the increasing development of medicine today, the clinical application of neoadjuvant chemotherapy has brought new hope to the ...
Junsha An, Cheng Peng, Hailin Tang, Xiuxiu Liu, F. Peng   +4 more
semanticscholar   +1 more source

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol. [PDF]

, 2019
Dedicated breast positron emission tomography (dbPET) is an emerging technology with high sensitivity and spatial resolution that enables detection of sub-centimeter lesions and depiction of intratumoral heterogeneity.
Chien, Amy J, Esserman, Laura J, Franc, Benjamin L, Hylton, Nola M, Joe, Bonnie N, Jones, Ella F, Li, Wen, Mukhtar, Rita A, Pampaloni, Miguel H, Ray, Kimberly M, Seo, Youngho   +10 more
core   +2 more sources

Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial

Cancer, 2021
The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study investigated the benefit of neoadjuvant chemotherapy according to prognostic stratification based on the Sarculator nomogram for STS.
S. Pasquali, E. Palmerini, V. Quagliuolo, J. Martín-Broto, A. López-Pousa, G. Grignani, A. Brunello, J. Blay, Oscar Tendero, R. Diaz-Beveridge, V. Ferraresi, I. Lugowska, G. Infante, L. Braglia, D. Merlo, V. Fontana, E. Marchesi, D. Donati, E. Palassini, G. Bianchi, A. Marrari, C. Morosi, S. Stacchiotti, S. Bagué, J. Coindre, A. D. Dei Tos, P. Picci, P. Bruzzi, R. Miceli, P. Casali, A. Gronchi   +30 more
semanticscholar   +1 more source

Efficacy and safety of neoadjuvant treatment with chemotherapy and immune checkpoint blockades for potentially resectable gastric cancer: A retrospective study

Human Vaccines & Immunotherapeutics
The efficacy and safety of adding immune checkpoint inhibitors (ICIs) to neoadjuvant chemotherapy in patients with potentially resectable gastric cancer (GC) are uncertain.
Huiyun Wang, Xuchen Zhang, Yulong Tian, Haitao Jiang, Ning Liu, Jinfeng Zhan, Yunqing Chen, Shanai Song, Xiao Huang, Man Jiang, Chuantao Zhang, Helei Hou   +11 more
doaj   +1 more source